{
    "title": "DiChloroAcetate: A cheap and simple cure for cancer?",
    "inventor_name": null,
    "publication_year": 2007,
    "device_name": "Dichloroacetate (DCA)",
    "goal": "Treat cancer by reactivating mitochondrial metabolism and inducing apoptosis in cancer cells",
    "problem_addressed": "Cancer (metabolic dysregulation and uncontrolled cell growth)",
    "concept_summary": "Dichloroacetate (DCA) is a small, inexpensive molecule that inhibits pyruvate dehydrogenase kinase, thereby re-activating mitochondrial oxidative phosphorylation in cancer cells. This metabolic shift from glycolysis to mitochondrial respiration triggers apoptosis, leading to tumor regression in vitro and in animal models while sparing normal tissue.",
    "detailed_description": null,
    "category": "Medical & Dental Technologies",
    "principles": [
        "Inhibition of pyruvate dehydrogenase kinase (PDK)",
        "Activation of pyruvate dehydrogenase (PDH)",
        "Metabolic re-programming from glycolysis to oxidative phosphorylation",
        "Induction of apoptosis in cancer cells"
    ],
    "scientific_domains": [
        "Biochemistry",
        "Oncology",
        "Pharmacology",
        "Molecular Biology"
    ],
    "mechanisms_of_action": [
        "DCA blocks PDK, preventing PDH inactivation",
        "Restores mitochondrial function and ATP production",
        "Reverses the Warburg effect in cancer cells",
        "Promotes apoptotic pathways leading to cell death"
    ],
    "materials": [
        "Dichloroacetate",
        "Ceresine (alternative name)"
    ],
    "energy_sources": [],
    "inputs": [
        "Oral or aqueous administration of DCA",
        "Cancer cells (in vitro or tumor xenografts in vivo)"
    ],
    "outputs": [
        "Cancer cell death",
        "Tumor shrinkage",
        "Reduced tumor growth"
    ],
    "claimed_performance": "In vitro, DCA killed lung, breast and brain cancer cells while sparing normal cells; in rat models bearing human tumour xenografts, tumours shrank dramatically after several weeks of DCA-laced water.",
    "experimental_evidence": "Laboratory studies showed loss of immortality and death of cancer cells; animal studies reported tumour regression in rats fed DCA-containing water; results published in the journal Cancer Cell.",
    "replication_status": "Results published in Cancer Cell; no independent replication reported in the article.",
    "keywords": [
        "Dichloroacetate",
        "DCA",
        "Cancer metabolism",
        "Warburg effect",
        "Mitochondrial activation",
        "PDK inhibition",
        "Apoptosis"
    ],
    "related_technologies": [
        "Other metabolic modulators",
        "PDK inhibitors",
        "Mitochondrial targeting drugs"
    ],
    "controversy_level": "medium",
    "confidence_score": 0.8,
    "practicability_score": 0.6,
    "fringe_score": 0.4,
    "evidence_strength": 0.5,
    "risk_score": 0.3,
    "trl_estimate": 4,
    "source_urls": [
        "http://www.futurepundit.com/archives/004028.html",
        "http://www.depmed.ualberta.ca/dca",
        "http://www.sciencedirect.com/science/article/pii/S0048969708001234",
        "http://www.cancercell.com/content/9/3/215",
        "http://www.ncbi.nlm.nih.gov/pubmed/18322191"
    ],
    "organizations": [
        "University of Alberta",
        "Alberta Cancer Board",
        "Canadian Institutes for Health Research"
    ],
    "applications": [
        "Cancer therapy (potential monotherapy or adjunct)",
        "Metabolic re-programming of tumour cells"
    ],
    "limitations": [
        "No human clinical trials yet",
        "Potential peripheral neuropathy at therapeutic doses",
        "Lack of patent protection limiting commercial investment",
        "Unclear optimal dosing and treatment schedule"
    ],
    "open_questions": [
        "Does DCA demonstrate efficacy and safety in human cancer patients?",
        "What is the optimal dose that maximizes tumour regression while minimizing toxicity?",
        "Can DCA be effectively combined with existing chemotherapies or anti-angiogenic agents?",
        "What are the long-term effects of chronic DCA administration?"
    ],
    "red_flags": [
        "Claims of a universal cure for cancer without human trial data",
        "Potential over-statement of efficacy based on pre-clinical results only"
    ],
    "evidence_quotes": [
        "In tests, the DCA caused cancer cells to lose their immortality and die.",
        "When the drug was given to rats with human tumours, the tumours shrank.",
        "DCA normalized the mitochondrial function in many cancers, showing that their function was actively suppressed by the cancer but was not permanently damaged by it.",
        "The normalization of mitochondrial function resulted in a significant decrease in tumor growth both in test tubes and in animal models.",
        "DCA, unlike most currently used chemotherapies, did not have any effects on normal, non-cancerous tissues."
    ]
}